“Mechanistic Insights into Dystroglycan Glycosylation and Post-translational Processing”, Duke University Biochemistry Seminar, Durham, NC, October 3, 2014. |
“Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies”, Texas A&M University Neuroscience Seminar, College Station, TX, September 18, 2014. |
“Genetics of dystroglycanopathies: new advances in dystroglycan post-translational processing”, Baylor University College of Medicine Seminar, Houston, TX, September 9, 2014. |
“Mechanistic Insights into Muscular Dystrophy from Bench to Bedside and Back to the Bench Studies”, UCLA Neurology Grand Rounds, University of California, Los Angeles, CA, April 9, 2014 |
"Mechanistic Insights into Dystroglycan Glycosylation from Bench to Bedside and Back to the Bench Studies," Pediatrics Frontiers in Research seminar, University of Iowa, Iowa City, IA, February 24, 2014. |
"Mechanistic Insights into Dystroglycan Glycosylation and Muscular Dystrophy," Cincinnati Children's Heart Institute Seminar Series, Cincinnati, OH, February 10, 2014. |
"Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies," University of Georgia, Athens, GA, December 4, 2013. |
"Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies," Cornell Physiology Biophysics and Systems Biology Seminar Series, New York, NY, October 28, 2013. |
"Mechanistic Insights into Dystroglycan Glycosylation and Muscular Dystrophy," EMBO Workshop on Muscle Wasting, Ascona, Switzerland, September 19, 2013. |
"Novel Glycosylation Required for Skeletal Muscle Function," John and Margaret Faulkner Lectureship, University of Michigan, Ann Arbor, MI, June 19, 2013. |
"Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies," Segawa Neurological Clinic for Children Symposium, Tokyo, Japan, June 2, 2013. |
"Patient fibroblast alpha-dystroglycan glycosylation studies: A versatile tool for developing therapies to treat dystroglycanopathies," The 55th Annual Meeting of the Japanese Society of Child Neurology, Oita, Japan, May 31, 2013. |
"Fukuyama congenital muscular dystrophy," The 55th Annual Meeting of the Japanese Society of Child Neurology, Oita, Japan, May 30, 2013. |
"Novel Glycosylation Enzymes Required for Dystroglycan Function as an Extracellular Matrix Receptor," Dept. of Biological Chemistry Seminar Program, Johns Hopkins University, Baltimore, MD, May 21, 2013. |
"Molecular insights into the pathogenesis of glycosylation-deficient muscular dystrophy," Johnson-Sokatch Lectureship, University of Oklahoma, Oklahoma City, OK, May 15, 2013. |
"Molecular Basis for Dystroglycan Binding to Laminin-G Domain-Containing Ligands," ASBMB Annual Meeting, Boston, MA, April 21, 2013. |
"Dystroglycan Function Requires Xylosyltransferase and Glucuronyltransferase Activities of LARGE," Glycosylation Workshop, Charlotte NC, April 18, 2013. |
"Genetics and Glycobiology of Dystroglycanopathies," Gordon Glycobiology Research Conference, Ventura, CA, March 6, 2013. |
"Development of the Iowa Wellstone Muscular Dystrophy Center: From Bench to Bedside and Back to the Bench." Center for Muscle Biology Fall Retreat, University of Kentucky, Lexington, KY, October 25, 2012. |
“Mechanistic Insights into Muscular Dystrophy Pathogenesis from Bench to Bedside and Back to the Bench Studies," College of Medicine Dean's Distinguished Lecture, University of Kentucky, Lexington, KY, October 24, 2012. |
Panel Discussion: Disease Pathogenesis, Wellstone Centers Meeting, Watertown, MA, October 18, 2012. |
“Patient fibroblast functional complementation studies: A valuable tool in the identification of novel WalkerWarburg syndrome disease genes, " World Muscle Society Meeting, Perth, Australia, October 10, 2012. |
"Novel Glycosylation Pathways Required for Dystroglycan Function," Duke University, Durham, NC, September 20, 2012. |
“Molecular basis for dystroglycan binding to the muscle basal lamina” Institut Pasteur, Paris, France, July 2, 2012. |
Preclinical Work - Research Updates, Congenital Muscle Disease Forum - satellite meeting, New Directions in Biology and Disease of Skeletal Muscle Conference, New Orleans, LA, June 19, 2012. |
"Molecular basis for dystroglycan binding to the muscle basal lamina" Frontiers in Myogenesis Meeting, New York, NY, June 6, 2012. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” Yeshiva University, Einstein College of Medicine, Bronx, NY, May 4, 2012. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Nebraska-Lincoln, Lincoln, NE, April 25, 2012. |
"Mechanistic and Molecular Insights into Dystroglycan Glycosylation,” CMD: Exploring the Role of Myomatrix, Reno, NV, April 24, 2012. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” Iowa State University, Ames, IA, March 27, 2012. |
"Animal models and how they have contributed to our knowledge of the disease pathogenesis” and “LARGE up-regulation,” ENMC Dystroglycan and Dystroglycanopathies Workshop, Naarden, The Netherlands, November 12-13, 2011. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” Kurt Ebner Discovery Lecture, Kansas City, KS, October 31, 2011. |
"Dysferlin and Muscle Membrane Repair,” Coalition to Cure Calpain3 LGMD2A Workshop, Santa Monica, CA, October 27, 2011. |
“Genetics and Molecular Pathogenesis of Dystroglycanopathies,” Wellstone Muscular Dystrophy Cooperative Research Center meeting, Columbus, OH, October 14, 2011. |
"Role of Glycosylation in Muscle Dystrophies,” International Conference on Muscle Wasting, Ascona, Switzerland, September 22, 2011. |
“Glycobiology and Cell-Matrix Interactions: Insights from Dystroglycan Function,” Gordon Research Conference on Collagen, New London, NH, July 21, 2011. |
“Mechanistic and Molecular Insights into the Pathogenesis of Glycosylation-Deficient Muscular Dystrophy,” AANP Annual Meeting, Presidential Symposium, Seattle, WA, June 26, 2011. |
“Mechanistic and molecular insights into the pathogenesis of muscular dystrophy,” Nationwide Children’s Hospital, The Ohio State University, Columbus, OH, June 2, 2011. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” The Sanford-Burnham Medical Research Institute, La Jolla, CA, April 26, 2011. |
“Dystrophin-Glycoprotein Complex and Molecular Pathogenesis of Duchenne Muscular Dystrophy,” 1st Chinese Conference on Translational Research in Duchenne Muscular Dystrophy, Guangzhou, China, April 7, 2011. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of California San Francisco, Gladstone Institute, San Francisco, CA, March 21, 2011. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of California Davis, Davis, CA, March 3, 2011. |
“Molecular Basis of Glycosylation-deficient Muscular Dystrophy and Approaches to Therapy,” Sanford-Burnham Rare Disease Symposium, La Jolla, CA, February 25, 2011. |
University of California San Diego, Glycobiology Symposium, San Diego, CA, February 18, 2011. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of California San Diego, San Diego, CA, February 17, 2011. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” NGM Biopharmaceuticals, Inc., San Francisco, CA, January 26, 2011. |
“Glycosylation and Dystroglycan Function in Congenital Muscular Dystrophy,” Children's National Medical Center, December 2, 2010. |
“Distinct Functions of Glial and Neuronal Dystroglycan in the Developing and Adult Mouse Brain,” LGMD-CMD Meeting, Charlotte, NC, November 11, 2010. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Texas Southwestern, Dallas, TX, November 3, 2010. |
“Novel Post-Translational Processing of Dystroglycan: Insights from Muscular Dystrophy Patients,” ASMB meeting, October 24, 2010. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Wisconsin, Cardiovascular Research Conference, Madison, WI, September 21, 2010. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” XII International Congress on Neuromuscular Diseases, Naples, Italy, July 22, 2010. |
“Molecular Basis of Glycosylation-deficient Muscular Dystrophy and Approaches to Therapy,” University of Texas Health Science Center – Houston, Institute of Molecular Medicine, Houston, TX, June 25, 2010. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Minnesota, Lillehei Heart Institute, Minneapolis, MN, June 9, 2010. |
“Mechanistic and Molecular Insights into the Pathogenesis of Muscular Dystrophy,” University of Nebraska Medical Center, Omaha, NE, June 8, 2010. |
“Mechanistic and Molecular Insights into Fatigue in Muscular Dystrophy,” Ottawa Conference on New Directions in Biology & Disease in Skeletal Muscle, Ottawa, Ontario, Canada, May 5, 2010. |
“Novel Post-Translational Processing of Dystroglycan: Insights from Muscular Dystrophy Patients,” University of Georgia, Athens, GA, April 23, 2010. |
“Molecular Basis of Glycosylation-deficient Muscular Dystrophy and Approaches to Therapy,” Genzyme Corp., Framingham, MA, April 2, 2010. |
“Novel Post-Translational Processing of Dystroglycan: Insights from Muscular Dystrophy Patients,” Loyola University Chicago, Chicago, IL, March 31, 2010. |
“Novel Post-Translational Processing of Dystroglycan: Insights from Muscular Dystrophy Patients,” University of California Santa Barbara, Santa Barbara, CA, February 25, 2010. |
"Current Understanding of Dysferlin and Membrane Repair,”ENMC Workshop on Dysferlinopathy, Naarden, The Netherlands, January 30, 2010. |
|